Althera® Versus Nutramigen / Cow's Milk Intolerance

NCT01727115 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2012-11-15

No results posted yet for this study

Summary

The primary objective of this study is to demonstrate that ALTHERA® is equal or superior in efficacy than NUTRAMIGEN®

Conditions

  • Allergy

Interventions

OTHER

Infant Formula Feeding

Assigned formula (Althera® or Nutramigen®) for a 4 weeks period. * If the challenge is positive: The children continue the assigned formula * If the challenge is negative: A Follow up formula is given * (Nan pro2) if child \> 6 months * (Nan pro1) if child \< 6 months

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Yvan Vandenplas, Professor · AZ-Kinderen V.U.B.

  • Bruno Hauser, Doctor · AZ-Kinderen V.U.B.

  • Thierry Devreker, Doctor · AZ-Kinderen V.U.B.

  • Marc Verghote, Doctor · CHR Namur

  • Christine Halut, Doctor · CHR Namur

  • Olivia Bauraind, Doctor · Clinique Saint Pierre

  • Sandra Mulier, Doctor · CHU des Enfants Reine Fabiola

  • Pascal Lenoir, Doctor · Clinique Notre Dame Tournai

  • Etienne Sokal, Professor · Clinique Universitaire Saint Luc

  • Francoise Smets, Doctor · Clinique Universitaire Saint Luc

  • Francoise Bury, Doctor · Clinique de l'Espérance

  • Stéphanie Colinet, Doctor · Clinique de l'Espérance

  • Stefaan Peeters, Doctor · Aalsters Stedelijk ziekenhuis

  • Patrick Bollen, Doctor · AZ Vesalius

  • Paul Mariën, Doctor · Sint Augustinus

  • Gigi Veereman, Professor · Paola Kinderziekenhuis

  • Myriam VanWinckel, Professor · UZ Gent

  • Jozef Christens, Doctor · Maria Ziekenhuis Noord Limburg

  • Kristien Kamoen, doctor · Algemeen Ziekenhuis Maria Middelares

  • Michèle Scaillon, Doctor · CHU des Enfants Reine Fabiola

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-10-31
Completion
2011-07-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01727115 on ClinicalTrials.gov